Kinetic mechanism of protease inhibition by α1-antitrypsin

被引:14
|
作者
Kang, UB
Baek, JH
Ryu, SH
Kim, J
Yu, MH
Lee, C
机构
[1] Korea Inst Sci & Technol, Ctr Biomed Res, Seoul 130650, South Korea
[2] Korea Inst Sci & Technol, Funct Proteom Ctr, Seoul 130650, South Korea
[3] Korea Univ, Biochem Lab, Sch Life Sci & BIotechnol, Seoul 136701, South Korea
关键词
acyl intermediate; alpha(1)-antitrypsin; rapid-quench study; rate-determining step; salt bridge; serpin; stopped-flow experiment;
D O I
10.1016/j.bbrc.2004.08.105
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The native form of serine protease inhibitor (serpin) is kinetically trapped in a metastable state. Metastability in these proteins is critical to inhibit target protease by forming a stable covalent complex. Despite recent determination of the crystal structures of a Michaelis protease-serpin complex as well as a stable covalent complex, details on the kinetic mechanism remain unsolved. In this report, we examined the reaction mechanism of alpha(1)-antitrypsin toward elastase by a combination of stopped-flow experiments via fluorescence resonance energy transfer and rapid-quench studies. The results suggest a non-covalent complex intermediate other than Michaelis complex as an intermediate before the cleavage of P1-P1' scissile bond, whose formation is the rate-determining step of the overall reaction. This rate-limiting step represents rearrangement of the reactive site loop, and is regulated by a Salt bridge between E354 and R196. The ionic interaction is unique to alpha(1)-antitrypsin, which suggests that protease inhibition mechanisms are varied among serpins. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:409 / 415
页数:7
相关论文
共 50 条
  • [41] α1-Antitrypsin deficiency in childhood
    Teckman, Jeffrey H.
    SEMINARS IN LIVER DISEASE, 2007, 27 (03) : 274 - 281
  • [42] Genetic Variants of α1-Antitrypsin
    Salahuddin, Parveen
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2010, 11 (02) : 101 - 117
  • [43] Alpha 1-antitrypsin deficiency
    Rooney, C
    Taggert, C
    O'Neill, SJ
    McElvaney, NG
    Coakley, R
    IRISH MEDICAL JOURNAL, 1999, 92 (01) : 227 - 228
  • [44] A Review of α1-Antitrypsin Deficiency
    Stoller, James K.
    Aboussouan, Loutfi S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (03) : 246 - 259
  • [45] α1-antitrypsin deficiency panniculitis
    McBean, J
    Sable, A
    Maude, J
    Bostom, LR
    CUTIS, 2003, 71 (03): : 205 - 209
  • [46] Alpha 1-antitrypsin deficiency
    Mornex, J. -F.
    REVUE DES MALADIES RESPIRATOIRES, 2022, 39 (08) : 698 - 707
  • [47] Exacerbations in α1-antitrypsin deficiency
    Needham, M
    Stockley, RA
    EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (06) : 992 - 1000
  • [48] Folding and export of α1-antitrypsin
    Wada, I
    Kanoh, H
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 468A - 468A
  • [49] Comment:: Comparisons of Aralast and Prolastin, α1-protease inhibitors for treatment of α1-antitrypsin deficiency
    Petteway, SR
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (02) : 353 - 354
  • [50] PROTEASE INHIBITION BY ALPHA-1-PROTEASE INHIBITOR (ALPHA-1-ANTITRYPSIN)
    BLOOM, JW
    HUNTER, MJ
    BIOPHYSICAL JOURNAL, 1976, 16 (02) : A53 - A53